1. World Health Organization. Director-General’s opening remarks at the media briefing on COVID-19. 11 March 2020. Available from URL: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march- 2020.
2.
World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva: WHO; 2020. Available from URL: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).
3.
Barry M, Ghonem L, Alsharidi A, et al. Coronavirus disease-2019 pandemic in the Kingdom of Saudi Arabia: mitigation measures and hospital preparedness. J Nat Sci Med 2020; 3: 155–158.
4.
World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. 2021 [cited 15.12.2021]. Available from URL: www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.
5.
Taylor L. Covid-19: Omicron drives weekly record high in global infections. BMJ 2022; 376: o66, doi: 10.1136/bmj.066.
6.
The Washington Post. The Boris Johnson reports U.K.’s first known death of patient with omicron variant. 2021 [cited 15.12.2021]. Available from URL: https://www.washingtonpost.com/world/britain-omicron-death-variant-coronavirus/2021/12/13/cd87da44-5c0a-11ec-b1ef-cb78be717f0e_story.html.
7.
Brandal LT, MacDonald E, Veneti L, et al. Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. Euro Surveill 2021; 26(50).
8.
Iacobucci G. Covid-19: runny nose, headache, and fatigue are commonest symptoms of omicron, early data show. BMJ 2021; 375: n3103.
9.
Kumar S, Thambiraja TS, Karuppanan K, et al. Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein. J Med Virol 2022; 94: 1641–1649, doi: 10.1002/jmv.27526.
10.
Romero-Gameros CA, Colin-Martínez T, Waizel-Haiatet S, et al. Diagnostic accuracy of symptoms as a diagnostic tool for SARS-CoV 2 infection: a cross-sectional study in a cohort of 2,173 patients. BMC Infect Dis 2021; 21(1): 255, doi: 10.1186/s12879-021-05930-1.
11.
Bhatla A, Mayer MM, Adusumalli S, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm 2020; 17(9): 1439–1444.
12.
Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 2008; 3: 127–155.
13.
Kociol RD, Cooper LT, Fang JC. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation 2020; 141: e69–e92.
14.
Giudicessi JR, Noseworthy PA, Friedman PA, et al. Urgent guidance for navigating and circumventing the QTc prolonging and torsadogenic potential of possible pharmacotherapies for COVID-19. Mayo Clin Proc 2020; 95(6): 1213–1221, doi: 10.1016/j.mayocp.2020.03.024.
15.
Karjalainen J, Viitasalo M. Fever and Cardiac Rhythm. Arch Intern Med 1986; 146(6): 1169–1171.
16.
Fever. Merck Manual Professional Version [cited 27.08.2019]. Available from URL: https://www.merckmanuals.com/professional/infectious-diseases/biology-of-infectiousdisease/fever?query=Fever%20in%20Adults.
17.
Uptodate. Approach to A child with Tachycardia. Available from URL: https://www.uptodate.com/contents/approach-to-the-child-withtachycardia?search=in%20febrile%20children%20with%20sinus%20tachycardia,%2the%20heart%20rate%20increase%20attributable%20to%20elevated%20temperature&s ource=search_result&selectedTitle=1~150&usage_type=default&display_rank=1.
18.
Hsieh JYC, Kan JYL, Mattar SAM, et al. The clinical implications of sinus tachycardia in mild COVID-19 infection: a retrospective cohort study. SAGE Open Med 2021; 9: 20503121211054973, doi: 10.1177/20503121211054973.
19.
WHO. Tacking SARS-COV-2 variants. Available from URL: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/.
20.
Announcement of first Omicron variant case in Saudi Arabia-CNN news. Available from URL: https://arabic.cnn.com/health/article/2021/12/01/saudi-first-omicron-case.
21.
He J, Wu B, Chen Y, et al. Characteristic electrocardiographic manifestations in patients with COVID-19. Can J Cardiol 2020; 36: 966.e1–966.e4.
22.
Cho JH, Namazi A, Shelton R, et al. Cardiac arrhythmias in hospitalized patients with COVID-19: a prospective observational study in the western United States. PLoS ONE 2020; 15: e0244533.
23.
Stealth Omicron Symptoms: Sore Throat, Elevated Heart Rate and Other Symptoms to Watch Out For! Available from URL: https://www.india.com/health/stealth-omicron-symptoms-sore-throat-elevated-heart-rate-and-other-symptoms-to-watch-out-for-5287498/.
24.
Trevano FQ, Seravalle G, Macchiarulo M, et al. Reliability of heart rate as neuroad-renergic marker in the metabolic syndrome.
25.
J Hypertens 2017; 35: 1685–1690.
26.
Maloberti A, Ughi N, Bernasconi DP, et al. Heart Rate in Patients with SARS-CoV-2 Infection: Prevalence of High Values at Discharge and Relationship with Disease Severity. J Clin Med 2021; 10(23): 5590.